Prescribing Information
Formularios en Español
For Healthcare Professionals
Other Treatment Options
Important Safety Information
Prescribing Information
CINRYZE
®
(C1 esterase inhibitor [human]) is an injectable prescription medicine that is used to help prevent swelling and/or painful attacks in children (6 years of age and older), teenagers and adults with Hereditary Angioedema (HAE).
Understanding HAE
What Is HAE?
HAE Symptoms and Triggers
Treatment Guidelines
About CINRYZE
What Is CINRYZE?
Effectiveness of CINRYZE
How Is CINRYZE Administered?
FAQ
CINRYZE Support
Getting Started With Takeda Patient Support
Self-Administration Training
Co-Pay Assistance
CINRYZE Resources
Resource Library
Glossary of Terms
Sign Up
Other Treatment Options
TAKHZYRO
®
(lanadelumab-flyo) injection
Firazyr
®
(icatibant injection)
cinryze
®
(C1 esterase inhibitor [human])
Understanding HAE
What Is HAE?
HAE Symptoms and Triggers
Treatment Guidelines
About CINRYZE
What Is CINRYZE?
Effectiveness of CINRYZE
How Is CINRYZE Administered?
FAQ
CINRYZE Support
Getting Started With Takeda Patient Support
Self-Administration Training
Co-Pay Assistance
CINRYZE Resources
Resource Library
Glossary of Terms
Sign Up
Formularios en Español
For Healthcare Professionals
Other Treatment Options
Main Menu
Other Treatment Options
TAKHZYRO
®
(lanadelumab-flyo) injection
Firazyr
®
(icatibant injection)
cinryze
®
(C1 esterase inhibitor [human])
Site Map
Home
Understanding HAE
What Is HAE?
HAE Symptoms and Triggers
Treatment Guidelines
About CINRYZE
What Is CINRYZE?
Effectiveness of CINRYZE
How Is CINRYZE Administered?
FAQ
CINRYZE Support
Getting Started With Takeda Patient Support
Self-Administration Training
Co-Pay Assistance
CINRYZE Resources
Resource Library
Glossary of Terms
Sign Up
Definition: